Trial Profile
Tri-therapy (SPINALON)-Elicited Spinal Locomotor Network Activation: Phase I-IIa Clinical Trial in Patients With Chronic Spinal Cord Injury
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Buspirone/carbidopa/levodopa (Primary)
- Indications Spinal cord injuries
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Nordic life science pipeline
- 28 Jan 2016 New trial record